Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 12, 2007. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on June 11, 2007. Each individual acquired 9 shares through the personal contribution element and 9 shares through the company matching element of the ShareReward Plan. The transaction price was GBP 13.08 per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share purchases described above.
Key Facts for Investor Verification
- Transaction Date: June 11, 2007.
- Share Price: GBP 13.08 per Ordinary Share.
- Participants: Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty.
- Volume per Participant: 18 shares total (9 personal, 9 company match).
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.